Rishi Gupta - Insider Trading & Ownership

Entity
Individual
Location
C/O Chemocentryx, Inc., 850 Maude Avenue, Mountain View, CA
Summary
The estimated net worth of Rishi Gupta is at least $245M dollars as of July 2, 2024. Rishi Gupta is the Director, 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $170M. Rishi Gupta is the Director of Verona Pharma plc and owns shares of Verona Pharma plc (VRNA) stock worth about $75.6M.
All Insider Reports
All Insider Reports

Ownership of Rishi Gupta

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. Director, 10%+ Owner $170M -$22.9M -11.9% May 16, 2024
VRNA Verona Pharma plc Director $75.6M May 11, 2023
TSBX Turnstone Biologics Corp. Director, 10%+ Owner Jun 3, 2024

Insider Transactions Reported by Rishi Gupta:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.